To evaluate the effect of cisplatin in PKCδ deficient conditions and to correlate it with tumor hypoxia, PKCδ deficient B16F10 melanoma cells were incubated in hypoxia chamber, where oxygen tension was maintained at 90% lower than normoxic environment. Here, PRKCD is linked to melanoma.